POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF DULAFUX 100 MG SOLUTION FOR INFUSION, 1 PIECE - Turkey License 5c9d739daece5b926c0bd01d94ce13d4
Access comprehensive regulatory information for POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF DULAFUX 100 MG SOLUTION FOR INFUSION, 1 PIECE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 5c9d739daece5b926c0bd01d94ce13d4 with license number 2022/337and contains active ingredient Anidulafungin. The license is held by DEVA HOLDฤฐNG A.ล..
This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free Database
Powered by Pure Global AI
21,000+ Products
5c9d739daece5b926c0bd01d94ce13d4
License Details
Turkey SFDA License: 5c9d739daece5b926c0bd01d94ce13d4
Product Details
POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF DULAFUX 100 MG SOLUTION FOR INFUSION, 1 PIECE
TR: DULAFUX 100 MG ฤฐNFรZYONLUK รรZELTฤฐ HAZIRLAMADA KULLANILACAK KONSANTRE ฤฐรฤฐN TOZ, 1 ADET
Pharmaceutical Product

